VYCO (Vycor Medical) Cyclically Adjusted PB Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vycor Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vycor Medical  (OTCPK:VYCO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Vycor Medical Cyclically Adjusted PB Ratio Related Terms


Vycor Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Vycor Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vycor Medical Cyclically Adjusted PB Ratio Chart

Vycor Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 8.21 0.00 0.00

Vycor Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VYCO vs BTCY, FEED, ADMT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Vycor Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vycor Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vycor Medical's Cyclically Adjusted PB Ratio falls into.



Vycor Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Vycor Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Vycor Medical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.127/333.9520*333.9520
=-0.127

Current CPI (Jun. 2026) = 333.9520.

Vycor Medical Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.036 241.428 0.050
201612 -0.002 241.432 -0.003
201703 0.043 243.801 0.059
201706 0.043 244.955 0.059
201709 0.021 246.819 0.028
201712 0.004 246.524 0.005
201803 -0.014 249.554 -0.019
201806 -0.011 251.989 -0.015
201809 -0.019 252.439 -0.025
201812 -0.033 251.233 -0.044
201903 -0.041 254.202 -0.054
201906 -0.042 256.143 -0.055
201909 -0.051 256.759 -0.066
201912 -0.054 256.974 -0.070
202003 -0.060 258.115 -0.078
202006 -0.063 257.797 -0.082
202009 -0.071 260.280 -0.091
202012 -0.072 260.474 -0.092
202103 -0.080 264.877 -0.101
202106 -0.072 271.696 -0.088
202109 -0.073 274.310 -0.089
202112 -0.078 278.802 -0.093
202203 -0.082 287.504 -0.095
202206 -0.081 296.311 -0.091
202209 -0.087 296.808 -0.098
202212 -0.090 296.797 -0.101
202303 -0.095 301.836 -0.105
202306 -0.092 305.109 -0.101
202309 -0.099 307.789 -0.107
202312 -0.102 306.746 -0.111
202403 -0.108 312.332 -0.115
202406 -0.108 314.175 -0.115
202409 -0.110 315.301 -0.117
202412 -0.111 315.605 -0.117
202503 -0.117 319.799 -0.122
202506 -0.116 322.561 -0.120
202509 -0.121 324.800 -0.124
202512 -0.122 324.054 -0.126
202603 -0.127 330.213 -0.128
202606 -0.127 333.952 -0.127

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vycor Medical Business Description

Address 951 Broken Sound Boulevard, Suite 320, Boca Raton, FL, USA, 33487
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.